Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Bours

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Carcinogenesis|November 1, 1989
Relationship of serum selenium levels to tumor activity in acute non-lymphocytic leukemiaY Beguin, V Bours, J M Delbrouck, et al.
Cancer Gene Therapy|June 1, 2000
Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cellsC Lechanteur, M Moutschen, F Princen, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthmaF Bureau, G Bonizzi, N Kirschvink, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosisA C Hellin, M Bentires-Alj, M Verlaet, et al.
Gut|August 15, 2000
Combined suicide and cytokine gene therapy for peritoneal carcinomatosisC Lechanteur, P Delvenne, F Princen, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 1995
NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expressionP D Drew, G Franzoso, K G Becker, et al.
The EMBO Journal|October 1, 1993
The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sitesG Franzoso, V Bours, V Azarenko, et al.
Gene Therapy|January 13, 1998
HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma-derived peritoneal carcinomatosisC Lechanteur, F Princen, S Lo Bue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effectF Princen, P Robe, C Lechanteur, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosisC Lechanteur, F Princen, S Lo Bue, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Carcinogenesis|November 1, 1989
Relationship of serum selenium levels to tumor activity in acute non-lymphocytic leukemiaY Beguin, V Bours, J M Delbrouck, et al.
Cancer Gene Therapy|June 1, 2000
Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cellsC Lechanteur, M Moutschen, F Princen, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthmaF Bureau, G Bonizzi, N Kirschvink, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosisA C Hellin, M Bentires-Alj, M Verlaet, et al.
Gut|August 15, 2000
Combined suicide and cytokine gene therapy for peritoneal carcinomatosisC Lechanteur, P Delvenne, F Princen, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 1995
NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expressionP D Drew, G Franzoso, K G Becker, et al.
The EMBO Journal|October 1, 1993
The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sitesG Franzoso, V Bours, V Azarenko, et al.
Gene Therapy|January 13, 1998
HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma-derived peritoneal carcinomatosisC Lechanteur, F Princen, S Lo Bue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effectF Princen, P Robe, C Lechanteur, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosisC Lechanteur, F Princen, S Lo Bue, et al.
Pageof 11